ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 22 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $8,992,000 | +9.1% | 7,500,000 | 0.0% | 0.21% | -11.2% |
Q1 2019 | $8,239,000 | +11.6% | 7,500,000 | 0.0% | 0.23% | -17.4% |
Q4 2018 | $7,383,000 | -7.0% | 7,500,000 | 0.0% | 0.28% | +32.5% |
Q3 2018 | $7,942,000 | -6.1% | 7,500,000 | 0.0% | 0.21% | -4.5% |
Q2 2018 | $8,458,000 | +3.0% | 7,500,000 | 0.0% | 0.22% | -3.5% |
Q1 2018 | $8,214,000 | -5.0% | 7,500,000 | 0.0% | 0.23% | -19.6% |
Q4 2017 | $8,642,000 | -46.8% | 7,500,000 | -50.0% | 0.29% | -7.7% |
Q3 2017 | $16,238,000 | +105.3% | 15,000,000 | +100.0% | 0.31% | -22.1% |
Q2 2017 | $7,908,000 | -0.6% | 7,500,000 | 0.0% | 0.40% | -12.1% |
Q1 2017 | $7,958,000 | -8.5% | 7,500,000 | 0.0% | 0.45% | -26.8% |
Q4 2016 | $8,700,000 | -6.2% | 7,500,000 | 0.0% | 0.62% | +3.3% |
Q3 2016 | $9,279,000 | +14.3% | 7,500,000 | 0.0% | 0.60% | +6.4% |
Q2 2016 | $8,121,000 | +23.2% | 7,500,000 | 0.0% | 0.56% | -2.6% |
Q1 2016 | $6,590,000 | -11.7% | 7,500,000 | 0.0% | 0.58% | +4.7% |
Q4 2015 | $7,461,000 | -46.1% | 7,500,000 | -50.0% | 0.55% | -0.2% |
Q3 2015 | $13,846,000 | +63.1% | 15,000,000 | +100.0% | 0.55% | +8.2% |
Q2 2015 | $8,488,000 | -1.5% | 7,500,000 | 0.0% | 0.51% | -23.7% |
Q1 2015 | $8,621,000 | +9.3% | 7,500,000 | 0.0% | 0.67% | +1.4% |
Q4 2014 | $7,885,000 | – | 7,500,000 | – | 0.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|